The drug is used to treat Diabetes 2 and will come in 3 mg sizes.  BD 

The Food and Drug Administration approved Impax Laboratories Inc.’s generic copies of a diabetes drug.  Hayward-based Impax (NASDAQ: IPXL) plans to start selling the tablets, copies of Bayer’s Precose, in the fourth quarter of this year. They’ll be marketed in 25 mg, 50 mg and 100 mg sizes.

Impax gets FDA nod for diabetes drug - San Francisco Business Times:


Post a Comment

Google Analytics Alternative